Naseem S. Jouhari
FDA investigator
Appears on 1 document from 2018, mostly at sites in Missouri. Most often cites production record review (21 CFR 211.192).
- 1
- Documents on file
- 12.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 12 observations- 21 CFR 211.192Production record review2
- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.115(a)Reprocessing1
- 21 CFR 211.130(c)Packaging and labeling operations1
- 21 CFR 211.137(a)Expiration dating1
- 21 CFR 211.160(b)General requirements1
Activity by year
2018: 1
Where
Missouri 1
Often inspects with
Is Naseem S. Jouhari coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-04-19 | 483 Q A Laboratories IncApr 19, 2018 · Kansas City, Missouri | Kansas City, Missouri | 12 |
About this profile
What does Naseem S. Jouhari inspect?
Naseem S. Jouhari appears on 1 document on file covering 1 site, mostly in Missouri.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.100(b) and 21 CFR 211.115(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Naseem S. Jouhari is dated Apr 19, 2018.